Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone and N-Acetylcysteine for the Prevention of Atrial Fibrillation in Thoracic Surgery
NCT02750319Phase 3Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2016
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in Atrial fibrillation (AFib), sponsored by Memorial Sloan Kettering Cancer Center. Started Apr 2016; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02750319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02750319.